Article: Bernard Madoff, criminal financier, 1938-2021

Article - Media, Publications

Bernard Madoff, criminal financier, 1938-2021

Brooke Masters , 16 April 2021

When Bernard Madoff’s Ponzi scheme collapsed in December 2008, $65bn vanished overnight, devastating tens of thousands of small investors, charities and religious groups who continue to struggle to this day.

The former chair of the Nasdaq stock market’s confession that his fabled investment company was “one big lie” came at the depths of the financial crisis and riveted global attention. Amid an alphabet soup of opaque financial products that had crashed the world economy, people could understand this crime.
Continue reading “Article: Bernard Madoff, criminal financier, 1938-2021”

Article: About Credit Suisse X-Links Silver CovCall ETN

Article - Media, Publications

About Credit Suisse X-Links Silver CovCall ETN

U.S. News, 16 April 2021

The investment seeks a return linked to the performance of the Credit Suisse NASDAQ Silver FLOWSTM 106 Index. The index measures the return of a “covered call” strategy on the shares of the iShares® Silver Trust (the “SLV Shares”) by reflecting changes in the price of the SLV Shares and the notional option premiums received from the notional sale of monthly call options on the SLV Shares less notional transaction costs incurred in connection with the covered call strategy.

Read Full Article

Article: NANO-X IMAGING LTD Files 2020 Annual Report on Form 20-F

Article - Media, Publications

NANO-X IMAGING LTD Files 2020 Annual Report on Form 20-F

GLOBE NEWSWIRE, 06 April 2021

NANO-X IMAGING LTD (NASDAQ: NNOX) (www.nanox.vision) (“Nanox” or the “Company”), the innovative medical imaging technology company democratizing healthcare, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission (“SEC”) on April 6, 2021. The annual report on Form 20-F, which contains the Company’s audited consolidated financial statements, can be accessed on the SEC’s website at www.sec.gov and on the Company’s website at www.nanox.vision under “Financials” in the Investors section. Continue reading “Article: NANO-X IMAGING LTD Files 2020 Annual Report on Form 20-F”

Article: American Acquisition Opportunity Inc. Announces Partial Exercise of Over-Allotment Option in Connection With Its Initial Public Offering

Article - Media, Publications

American Acquisition Opportunity Inc. Announces Partial Exercise of Over-Allotment Option in Connection With Its Initial Public Offering

ACCESSWIRE, 02 April 2021

American Acquisition Opportunity Inc. (NASDAQ:AMAOU)(the “Company”) announced today that it has closed the issuance of an additional 506,002 units pursuant to the partial exercise of the underwriter’s over-allotment option in connection with the company’s initial public offering. The units are listed on the Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “AMAOU”. Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, shares of the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “AMAO” and “AMAOW,” respectively Continue reading “Article: American Acquisition Opportunity Inc. Announces Partial Exercise of Over-Allotment Option in Connection With Its Initial Public Offering”

Article: Bitcoin’s Price Is Not the Only Risk to Riot Blockchain

Article - Media, Publications

Bitcoin’s Price Is Not the Only Risk to Riot Blockchain

Vince Martin, 31 March 2021

Less than four years ago, Riot Blockchain (NASDAQ:RIOT) was a failed animal health company named Bioptix. What is now RIOT stock was then BIOP stock — and it traded for less than $4 per share.

That wasn’t because investors put much value on the business: Bioptix in fact had more than $2 per share in cash at the end of 2017’s second quarter. BIOP was basically just another penny stock in the biotech space.

But in October of that year, Bioptix rebranded to Riot Blockchain. It was a move that invited a huge rally — and quite a bit of skepticism.

Blockchain and other cryptocurrencies were hot then, with Bitcoin (CCC:BTC-USD) at one point rising from $900 to $20,000 during 2017. Riot was not alone in moving into crypto and blockchain: Eastman Kodak (NYSE:KODK) infamously was involved in a “KodakCoin” project which never came to fruition. That didn’t stop KODK stock from soaring. Continue reading “Article: Bitcoin’s Price Is Not the Only Risk to Riot Blockchain”

Article: No Surprise Here: Institutions Could Run Bitcoin’s Price Higher

Article - Media, Publications

No Surprise Here: Institutions Could Run Bitcoin’s Price Higher

ETF Trends, 31 March 2021

Institutions are slowly warming to Bitcoin, which many market observers believe will lead to substantial long-term price appreciation.

Institutional investors are playing an increasingly prominent role in the Bitcoin market, and that role is likely to continue growing. For smaller investors, there are tangible benefits to this scenario. Continue reading “Article: No Surprise Here: Institutions Could Run Bitcoin’s Price Higher”

Article: Fraudsters Siphon $100 Million In COVID Relief Through Online Investment Platforms

Article - Media, Publications

Fraudsters Siphon $100 Million In COVID Relief Through Online Investment Platforms

PYMNTS, 30 March 2021


Scammers stealing from government-funded pandemic relief programs have found a new trick — opening accounts with at least four online investment platforms, CNBC reported Monday (March 29).

Law enforcement officials say digital platforms are an easy way to dump money into stolen identity accounts.

Authorities say over $100 million in fraudulent funds reportedly passed through investment accounts in the time since Congress passed the CARES Act last March.

Among the platforms allegedly used by thieves are Robinhood, TD Ameritrade, E-Trade and Fidelity, according to law enforcement.

“The thieves are loving this stuff. This has been the financial crime bonanza act of 2021,” said Charles Intriago, a money-laundering expert and former federal prosecutor, according to CNBC. Continue reading “Article: Fraudsters Siphon $100 Million In COVID Relief Through Online Investment Platforms”

Article: Glass Houses Acquisition Corp. – EX-1.1 – – UNDERWRITING AGREEMENT BETWEEN THE COMPANY AND JEFFERIES LLC – March 26, 2021

Article - Media, Publications

Glass Houses Acquisition Corp. – EX-1.1 – – UNDERWRITING AGREEMENT BETWEEN THE COMPANY AND JEFFERIES LLC – March 26, 2021

Fintel, 26 March 2021

Introductory. Glass Houses Acquisition Corp., a Delaware corporation (the ?Company?), proposes, upon the terms and subject to the conditions set forth in this agreement (this ?Agreement?), to issue and sell to the several underwriters listed on Schedule A hereto (the ?Underwriters?) an aggregate of 20,000,000 units of the Company (the ?Units?). The 20,000,000 Units to be sold by the Company are called the ?Firm Securities.? In addition, the Company has granted to the Underwriters an option to purchase up to an additional 3,000,000 Units as provided in Section 2. The additional 3,000,000 Units to be sold by the Company pursuant to such option are collectively called the ?Optional Securities.? The Firm Securities and, if and to the extent such option is exercised, the Optional Securities are collectively called the ?Offered Securities.? Jefferies LLC (?Jefferies?) has agreed to act as the representative of the several Underwriters (in such capacity, the ?Representative?) in connection with the offering of the Offered Securities for sale to the public as contemplated in the Prospectus (as defined below) (the ?Offering?).

Read Full Article

Article: A Massive Increase in Trading in GameStop by Dark Pools Owned by the Mega Wall Street Banks Coincided with the Spike in its Share Price

Article - Media, Publications

A Massive Increase in Trading in GameStop by Dark Pools Owned by the Mega Wall Street Banks Coincided with the Spike in its Share Price

Pam Martens and Russ Martens,  26 March 2021

If the Securities and Exchange Commission is not taking a hard look at the involvement of Dark Pools owned by the biggest banks on Wall Street during the meteoric spike in the price of GameStop shares in late January, then we have to conclude that it doesn’t want to actually get at the truth.

Wall Street On Parade spent one hour combing through the Dark Pool trading data available through Wall Street’s self-regulator, FINRA, and the evidence of Dark Pools’ involvement in the dodgy trading in GameStop is striking. (GameStop is a New York Stock Exchange listed company and it has been trading like a penny stock operated out of a boiler room – raising questions about the integrity of U.S. markets.

Read Full Article

Article: Stocks Dump’n’Pump; Dollar Gains Amid Bitcoin, Bond Pain

Article - Media, Publications

Stocks Dump’n’Pump; Dollar Gains Amid Bitcoin, Bond Pain

Tyler Durden,25 March 2021

Thanks to yet another big short-squeeze that began shortly ahead of the EU close. This was the biggest short-squeeze since late January. Small Caps went from down over 1.5% ahead of the EU close to up over 2.5%. Nasdaq ended lower as late day selling pressure hit…

Before today, the last six days have seen the market has dropped in the last hour. S&P and Dow are back to unch on the week, Nasdaq remains red and Small Caps still down over 4.3%.Value outperformed Growth today but both ripped off the EU close…

Read Full Article

Article: Farmmi Closes $7.4 Million Underwritten Public Offering of Ordinary Shares

Article - Media, Publications

Farmmi Closes $7.4 Million Underwritten Public Offering of Ordinary Shares

PRNewswire, 24 March 2021

Farmmi, Inc. (“Farmmi” or the “Company”) (NASDAQ: FAMI), an agriculture products supplier in China, today announced the closing of an underwritten public offering of 6,469,467 ordinary shares of the Company, at a price to the public of $1.15 per share. In addition, the Company has granted the underwriter an option to purchase an additional 15 percent of the ordinary shares offered in the public offering solely to cover over-allotments, if any, exercisable for 25 days, after the closing of this offering, which would bring total gross proceeds to approximately $8.6 million. The Company intends to use the net proceeds from this offering for general corporate and working capital needs.

Read Full Article

Article: 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders

Article - Media, Publications

180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders

GLOBE NEWSWIRE, 24 March 2021

180 Life Sciences Corp. (NASDAQ: ATNF, the “Company”), a clinical-stage biotechnology company with its lead indication in Phase 2b/3 clinical trial, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today released the following letter to stockholders from its Chief Executive Officer, Dr. James Woody. Continue reading “Article: 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders”

Article: SEC Confirms Probe of SoftBank

Article - Media, Publications

SEC Confirms Probe of SoftBank

Michelle Celarier, 24 March 2021

SoftBank is the subject of an active investigation by the Securities and Exchange Commission, according to PlainSite, a legal transparency initiative.

The research provider on Wednesday shared the SEC’s response to a Freedom of Information Act request by Aaron Greenspan, the founder of PlainSite, a joint venture of Think Computer Corporation and Think Computer Foundation.

Greenspan said the SEC probe appears to be related to SoftBank’s trading unit, SB Northstar. He told Institutional Investor that news last year about SoftBank’s options trading triggered his initial FOIA request, which was dated December 2, 2020. Continue reading “Article: SEC Confirms Probe of SoftBank”

Article: Form 424B5 Farmmi, Inc.

Uncategorized

Form 424B5 Farmmi, Inc.

Toppan Merrill/FA, 23 March 2021

We are offering 6,469,467 ordinary shares, at a public offering price of $1.15 per ordinary share, pursuant to this prospectus supplement and the accompanying prospectus. See “Description of Ordinary Shares” in the accompanying prospectus for more information.

The ordinary shares trade on The Nasdaq Capital Market, or Nasdaq, under the symbol “FAMI”. On March 18, 2021, the last reported price of the ordinary shares on Nasdaq was $1.38 per ordinary share.

On March 19, 2021, the aggregate market value of our ordinary shares held by non-affiliates was approximately $16,260,024, based on 21,114,303 ordinary shares outstanding, 11,614,303 of which are held by non-affiliates, and a per ordinary share price of $1.40 based on the closing sale price of our ordinary shares on Nasdaq on March 19, 2021. We have not sold any of our ordinary shares pursuant to General Instruction I.B.5 on Form F-3 during the prior 12 calendar month period that ends on and includes the date hereof (but excluding this offering).

Read Full Article

Article: Bionano Genomics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates

Article - Media, Publications

Bionano Genomics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates

GLOBE NEWSWIRE, 23 March 2021

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results and business achievements for the fourth quarter and year ended December 31, 2020 and highlighted recent corporate updates.

“2020 was an important momentum-building year for Bionano and one that allowed us to showcase many of our strengths. Despite 2020’s challenges, we executed well on our commercial offerings for Saphyr® by expanding the number of systems in the field and the number of samples analyzed in our data services lab. We believe this progress helped create the awareness needed to develop the market for structural variation analysis and optical genome mapping, or OGM, furthering our goal of disrupting the genomics industry,” said Erik Holmlin, PhD, CEO of Bionano. “2021 is shaping up to be a transformational year for the company. Continue reading “Article: Bionano Genomics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates”